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rate is 0.04–0.1 per 100,000 (10). In this study, the detec-
tion rates of V. cholerae O1 in stools from patients with 
severe diarrhea were 23% (49/213 cases) in 2012 and 14% 
(35/250 cases) in 2013, respectively. Although our investi-
gation is merely the tip of the iceberg for studies of cholera 
in Myanmar, our data provide crucial initial insights into 
the genetic backgrounds of recent Yangon isolates of V. 
cholerae O1. Epidemiologic surveillance linked to labora-
tory investigations is need to minimize the risk for V. chol-
erae infection in children.
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To the Editor: We read with interest the study of gen-
der and age in nontuberculous mycobacterial (NTM) lung 
disease case-patients in Taiwan (1). NTM lung disease is 
relatively uncommon; however, the exact prevalence of 
NTM lung disease and causative organisms are largely 
unknown in many regions of the United States because 
the disease is not reportable. A recent study using Medi-
care claims data in the United States showed that the an-
nual prevalence of NTM lung disease increased from 20 
cases/100,000 persons in 1997 to 47 cases/100,000 per-
sons in 2007 (2). The study also showed that Hawaii had 
the highest period prevalence of cases (396 cases/100,000 
persons), which was at least partially attributed to the 
large Asian/Pacific Islander population (2). During June–
December 2011, we conducted a cross-sectional study to 
evaluate the epidemiologic and clinical significance of 
NTM isolated from patients in Honolulu, Hawaii; the pa-
tients had suspected pulmonary tuberculosis (TB) and were 
in airborne isolation at a university-affiliated, tertiary- 
care hospital.
NTM cases were defined according to the 2007 crite-
ria of the American Thoracic Society/Infectious Diseases 
Society of America (3). The process required to establish a 
diagnosis of NTM lung disease is sometimes lengthy; thus, 
patients who did not initially meet the disease criteria but 
who had cultures positive for NTM were reviewed again 1 
year after the original data were collected to see if follow-
up microbiological and radiographic studies would confirm 
the presence of NTM lung disease. Descriptive statistics 
were used to describe categorical and continuous variables. 
During June–December 2011, a total of 113 patients with 
suspected pulmonary TB were placed into isolation at the 
tertiary-care hospital. Of these patients, 85 (75.2%) were 
men and 28 (24.8%) were women; the median age was 
59.8 ± 17 years. Eighteen (15.9%) patients were white, 92 
(81.4%) were Asian/Pacific Islander, and 1 (0.9%) was Af-
rican American; for 2 (1.8%) patients, race/ethnicity was 
classified as not specified/other.
Of the 113 isolated patients, 21 (18.6%) were posi-
tive for mycobacteria. Of these 21 patients, 14 (66.7%) 
were men and 7 (33.3%) were women; the median age 
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was 64.3 ± 17.3 years. Three (14.3%) of these patients 
were white, and 18 (85.7%) were Asian/Pacific Islander. 
Mycobacterium tuberculosis and NTM were identified 
in samples from 3 (14.3%) and 18 (85.7%) of the 21 pa-
tients, respectively. Of the 18 patients with NTM-positive 
samples, 4 (22.2%) had definite NTM lung disease (all 
of these patients were Asian/Pacific Islander); 2 (11.1%) 
had probable NTM lung disease; and 12 (66.7%) had 
possible NTM lung disease. M. chelonae (identified by 
DNA sequencing) was the causative agent for most of the 
definite cases (n = 3, 75%), and the largest proportion of 
possible cases was caused by M. avian complex bacteria 
(n = 5, 41.7%).
Our finding that 22.2% (4/18) of the patients in Hono-
lulu with NTM-positive clinical samples during June–De-
cember 2011 received a definite diagnosis of NTM lung 
disease is slightly higher than but consistent with reports 
from other regions, which show that 9.8%–17.0% of such 
patients receive a definite NTM disease diagnosis (4,5). For 
unclear reasons, the number of NTM disease cases appears 
to be highest in Asian/Pacific Islander populations. Deter-
mining the reason(s) for this discrepancy should be the sub-
ject of future research efforts.
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To the Editor: The cynomolgus monkey (Macaca fas-
cicularis), also known as the long-tailed macaque or crab-
eating monkey, is commonly found in the Southeast Asia 
region (1). The macaque has been associated with several 
bacterial infections, such as those caused by hemotropic 
Mycoplasma and Bartonella quintana (2). As a result of 
rapid deforestation and changes in land use patterns, cyno-
molgus monkeys live in close proximity to human-popu-
lated areas (1). Human–macaque conflict may increase the 
risk for zoonoses. 
Little is known about rickettsial and anaplasma infec-
tions in cynomolgus monkeys in Malaysia. Although Rick-
ettsia spp. RF2125 and Rf31 have been identified from cat 
fleas in Malaysia (3), the presence of Anaplasma bovis in 
monkeys is not known.
Rickettsia felis, a member of the spotted fever group 
rickettsiae, is an emergent fleaborne human pathogen dis-
tributed worldwide (4). The obligate intracellular bacte-
rium has been identified from cats, dogs, opossums, and 
the ectoparasites of various mammalian hosts. Several 
uncultured rickettsiae genetically closely related to the R. 
felis–type strain URRWXCal2 (referred to as R. felis–like 
organisms and including Rickettsia spp. RF2125, Rf31, 
Candidatus Rickettsia asemboensis, and others) have also 
been identified from various arthropods and fecal samples 
of primates (5). A. bovis is a gram-negative, pleomorphic, 
tickborne intracellular bacterium that infects a wide range 
of mammal species in many geographic regions (6).
To learn more about these infections in monkeys, we 
examined blood samples from 50 cynomolgus monkeys 
caught by the Department of Wildlife and National Parks at 
12 residential areas in Peninsular Malaysia during a popula-
tion management and wildlife disease surveillance program 
(January 2012–December 2013). Most monkeys (14 male, 
36 female) were adults and were active and healthy. DNA 
was extracted from 200 μL of each blood sample by using a 
QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany). We 
performed PCRs selective for the rickettsial citrate synthase 
gene (gltA) by using primers CS-78 and CS-323 and for the 
135-kDa outer membrane protein B gene (ompB) by using 
primers 120-M59 and 120-807 (7). As positive controls, we 
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